US Patent Issued to 4D Molecular Therapeutics on April 14 for "Treatments for ocular neovascularization" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,680, issued on April 14, was assigned to 4D Molecular Therapeutics Inc. (Emeryville, Calif.).

"Treatments for ocular neovascularization" was invented by Christian Burns (Emeryville, Calif.), Melissa Calton (Emeryville, Calif.), Meredith Leong (Emeryville, Calif.) and Paul Szymanski (Emeryville, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions and methods for the treatment of ocular neovascular diseases such as wet age-related macular degeneration."

The patent was filed on Aug. 14, 2025, under Application No. 19/300,498.

*For further information, including images, charts and tables, please visit: http://patft....